PYPD
Price
$3.45
Change
+$0.05 (+1.47%)
Updated
Sep 5 closing price
Capitalization
54.85M
59 days until earnings call
SLGL
Price
$27.96
Change
-$0.04 (-0.14%)
Updated
Sep 5 closing price
Capitalization
77.89M
60 days until earnings call
Interact to see
Advertisement

PYPD vs SLGL

Header iconPYPD vs SLGL Comparison
Open Charts PYPD vs SLGLBanner chart's image
PolyPid
Price$3.45
Change+$0.05 (+1.47%)
Volume$24.88K
Capitalization54.85M
Sol-Gel Technologies
Price$27.96
Change-$0.04 (-0.14%)
Volume$26.73K
Capitalization77.89M
PYPD vs SLGL Comparison Chart in %
Loading...
PYPD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PYPD vs. SLGL commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PYPD is a StrongBuy and SLGL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 07, 2025
Stock price -- (PYPD: $3.45 vs. SLGL: $27.96)
Brand notoriety: PYPD and SLGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PYPD: 28% vs. SLGL: 119%
Market capitalization -- PYPD: $54.85M vs. SLGL: $77.89M
PYPD [@Biotechnology] is valued at $54.85M. SLGL’s [@Biotechnology] market capitalization is $77.89M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PYPD’s FA Score shows that 1 FA rating(s) are green whileSLGL’s FA Score has 0 green FA rating(s).

  • PYPD’s FA Score: 1 green, 4 red.
  • SLGL’s FA Score: 0 green, 5 red.
According to our system of comparison, PYPD is a better buy in the long-term than SLGL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PYPD’s TA Score shows that 4 TA indicator(s) are bullish while SLGL’s TA Score has 2 bullish TA indicator(s).

  • PYPD’s TA Score: 4 bullish, 4 bearish.
  • SLGL’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, PYPD is a better buy in the short-term than SLGL.

Price Growth

PYPD (@Biotechnology) experienced а +2.99% price change this week, while SLGL (@Biotechnology) price change was +22.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

PYPD is expected to report earnings on Nov 05, 2025.

SLGL is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SLGL($77.9M) has a higher market cap than PYPD($54.8M). SLGL YTD gains are higher at: 200.613 vs. PYPD (13.487). SLGL has higher annual earnings (EBITDA): -4.59M vs. PYPD (-33.1M). PYPD has more cash in the bank: 29.5M vs. SLGL (24.3M). SLGL has less debt than PYPD: SLGL (1.18M) vs PYPD (8.67M). SLGL has higher revenues than PYPD: SLGL (23.9M) vs PYPD (0).
PYPDSLGLPYPD / SLGL
Capitalization54.8M77.9M70%
EBITDA-33.1M-4.59M721%
Gain YTD13.487200.6137%
P/E RatioN/AN/A-
Revenue023.9M-
Total Cash29.5M24.3M121%
Total Debt8.67M1.18M734%
FUNDAMENTALS RATINGS
SLGL: Fundamental Ratings
SLGL
OUTLOOK RATING
1..100
68
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
41

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PYPDSLGL
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
78%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 5 days ago
78%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 10 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
PYPD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GDQMF0.500.02
+4.21%
Goldquest Mining Corp.
TKRFF0.05N/A
+2.05%
Tinka Resources Limited
DWHHF24.28N/A
N/A
Deutsche Wohnen SE
PRXXF19.10N/A
N/A
Paradox Interactive AB
WELUF12.19N/A
N/A
Integrated Wellness Acquisition Corp.

PYPD and

Correlation & Price change

A.I.dvisor tells us that PYPD and ELEV have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PYPD and ELEV's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PYPD
1D Price
Change %
PYPD100%
+1.47%
ELEV - PYPD
30%
Poorly correlated
N/A
SER - PYPD
27%
Poorly correlated
-3.60%
PRTA - PYPD
27%
Poorly correlated
+4.14%
SLGL - PYPD
26%
Poorly correlated
-0.14%
CING - PYPD
24%
Poorly correlated
+2.90%
More

SLGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLGL has been loosely correlated with TRAW. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if SLGL jumps, then TRAW could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLGL
1D Price
Change %
SLGL100%
-0.14%
TRAW - SLGL
47%
Loosely correlated
+7.51%
NEUP - SLGL
40%
Loosely correlated
-0.25%
RAPT - SLGL
39%
Loosely correlated
+1.57%
AZTR - SLGL
33%
Poorly correlated
-2.52%
GTBP - SLGL
33%
Poorly correlated
+1.72%
More